Targeted biopsy with MRI and ultrasound improves detection of high risk prostate cancer

Targeted magnetic resonance imaging (MRI)/ultrasound fusion biopsy, which superimposes MRI images on transrectal ultrasound images to highlight suspicious areas for biopsy, improves detection of high risk prostate cancer and reduces the detection of low risk cases compared with standard biopsies, a prospective US study has shown.1

The current diagnostic procedure for prostate cancer is a standard extended sextant biopsy, which takes a series of biopsies from the right and left …